148 related articles for article (PubMed ID: 20624131)
1. Vigabatrin: an antiepileptic drug with major benefits but significant adverse effects.
Besag FM
Curr Drug Saf; 2010 Jul; 5(3):188-90. PubMed ID: 20624131
[No Abstract] [Full Text] [Related]
2. Visual field constriction on vigabatrin.
Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin.
Sorri I
Acta Ophthalmol Scand; 2002 Jun; 80(3):343-4. PubMed ID: 12059879
[No Abstract] [Full Text] [Related]
4. Vigabatrin and epilepsy: further lessons in early childhood.
Parisi P; Bombardieri R; Curatolo P
Epilepsia; 2008 Jan; 49(1):177-8. PubMed ID: 18184225
[No Abstract] [Full Text] [Related]
5. Analysis of vigabatrin treatment causing visual field defects in infantile spasms.
Chiron C; Dulac O
Dev Med Child Neurol; 2015 Jan; 57(1):9-10. PubMed ID: 25109842
[No Abstract] [Full Text] [Related]
6. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
7. Balancing clinical benefits of vigabatrin with its associated risk of vision loss.
Pellock JM
Acta Neurol Scand Suppl; 2011; (192):83-91. PubMed ID: 22061183
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
Wohlrab G; Leiba H; Kästle R; Ramelli G; Schmitt-Mechelke T; Schmitt B; Landau K
Epilepsia; 2009 Aug; 50(8):2006-8. PubMed ID: 19682036
[No Abstract] [Full Text] [Related]
9. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
Prasad AN; Penney S; Buckley DJ
Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
[TBL] [Abstract][Full Text] [Related]
10. Is the risk of vigabatrin-attributed visual field loss lower in infancy than in later life?
Riikonen R
Epilepsia; 2009 Aug; 50(8):2005-6. PubMed ID: 19682035
[No Abstract] [Full Text] [Related]
11. Infantile spasms and vigabatrin. Visual field defects may be permanent.
Lhatoo SD; Sander JW
BMJ; 1999 Jan; 318(7175):57. PubMed ID: 10068225
[No Abstract] [Full Text] [Related]
12. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
13. Measuring field loss in children administered vigabatrin: a problem in search of a solution.
Good WV
J AAPOS; 2011 Oct; 15(5):411-2. PubMed ID: 22108349
[No Abstract] [Full Text] [Related]
14. Visual field defects associated with vigabratin monotherapy in children.
Luchetti A; Amadi A; Gobbi G
J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):566. PubMed ID: 11183043
[No Abstract] [Full Text] [Related]
15. Vigabatrin: an effective antiepilepsy drug--balancing the risk of visual dysfunction.
Krauss GL; Miller NR
Ann Pharmacother; 1999 Dec; 33(12):1367-8. PubMed ID: 10630838
[No Abstract] [Full Text] [Related]
16. Epilepsy: Vigabatrin treatment and visual field loss.
Chiron C; Dulac O
Nat Rev Neurol; 2011 Apr; 7(4):189-90. PubMed ID: 21364521
[No Abstract] [Full Text] [Related]
17. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
[TBL] [Abstract][Full Text] [Related]
18. Are vigabatrin-associated visual field constrictions asymptomatic?
Schmidt T; Rüther K; Schmitz B
J Neurol; 2004 Jul; 251(7):887-8. PubMed ID: 15258797
[No Abstract] [Full Text] [Related]
19. Vigabatrin for infantile spasms.
Pesaturo KA; Spooner LM; Belliveau P
Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
[TBL] [Abstract][Full Text] [Related]
20. Vigabatrin administration in patients with infantile spasms: the risks.
Jaseja H
Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
